Matsumoto, Akihiro
Imaizumi, Masayasu
Tanaka, Yasuhito
Nishiguchi, Shuhei
Yatsuhashi, Hiroshi
Ishida, Takehiko
Moriyama, Kazushige
Aoyagi, Katsumi
Tanaka, Eiji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15fk0210035h0001)
Japan Agency for Medical Research and Development (15fk0310012h0004)
Article History
Received: 29 March 2016
Accepted: 15 July 2016
First Online: 26 July 2016
Conflict of interest
: Masayasu Imaizumi, Kazushige Moriyama, and Katsumi Aoyagi are employees of Fujirebio, Inc. Takehiko Ishida and Katsumi Aoyagi are employees of Advanced Life Science Institute, Inc. Yasuhito Tanaka received lecture fees from Fujirebio, Inc., Chugai Pharmaceutical Co. Ltd, Bristol-Myers K.K, and GlaxoSmithKline K.K. Yasuhito Tanaka received a research grant from Chugai Pharmaceutical Co. Ltd. Hiroshi Yastuhashi received commercial research funding from Chugai Pharmaceutical Co. Ltd.